SMART Program Impact on QOL in Inflammatory Bowel Diseases

Overview

About this study

The purpose of this study is to assess the impact of a Stress Management and Resilience Training (SMART) Program on the quality of life and healthcare utilization of patients with inflammatory bowel disease.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

History of IBD defined by a physician global assessment (PGA) of quiescent, mild, moderate, or severe disease.
18 years old or older.
Access to internet/device such as smart phone, tablet or computer.
No corticosteroids in the previous 3 months.
Patient reports stress as a trigger to their GI symptoms.
No elicit substance use (including medical marijuana).

Exclusion Criteria:

< 18 Years of age.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 4/18/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Victor Chedid, M.D., M.S.	Closed for enrollment	Contact information: Alana English (507) 538-8014 Irlbeck.Alana@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Victor Chedid, M.D., M.S.

Closed for enrollment

Contact information:

Alana English

(507) 538-8014

Irlbeck.Alana@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials